CRF Health, the leading global provider of eCOA solutions for the life sciences industry, today announced the completion of the investment by funds managed and advised by Vitruvian Partners (“Vitruvian”), positioning Vitruvian as the majority shareholder of CRF Health. The transaction has now received all regulatory approvals.
Rachael Wyllie, who will continue to lead CRF Health as Chief Executive Officer, said: "We are very pleased to announce the completion of this investment by Vitruvian Partners. The management team look forward to working with Vitruvian to continue the development of CRF Health. Together we have ambitious plans for the growth of the company both from a resource and technology perspective to ensure high levels of customer satisfaction.”
Philip Russmeyer, a Partner at Vitruvian, added: “CRF Health has experienced phenomenal growth and we believe that through this investment we can bring new resources, strategic insight and scale that will take an already outstanding business to a new level. We look forward to working with CRF Health's executive team to further build on their vision and dedication to deliver patient-focused technology solutions with the highest quality outcomes for the pharmaceutical industry."
For further information on CRF Health, please visit http://www.crfhealth.com.